These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29129719)

  • 1. Non-protein amino acid derivatives of 25-methoxylprotopanaxadiol/25-hydroxyprotopanaxadioland their anti-tumour activity evaluation.
    Yuan W; Guo J; Wang X; Su G; Zhao Y
    Steroids; 2018 Jan; 129():1-8. PubMed ID: 29129719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng.
    Zhao Y; Wang W; Han L; Rayburn ER; Hill DL; Wang H; Zhang R
    Med Chem; 2007 Jan; 3(1):51-60. PubMed ID: 17266624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water-soluble derivatives of 25-OCH
    Zhou WX; Sun YY; Yuan WH; Zhao YQ
    Steroids; 2017 May; 121():32-39. PubMed ID: 28322864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of ginseng sapogenins, 25-OH-PPD and 25-OCH3-PPD, on gastric cancer cells.
    Zhao C; Su G; Wang X; Zhang X; Guo S; Zhao Y
    Biotechnol Lett; 2016 Jan; 38(1):43-50. PubMed ID: 26428367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activity of three novel derivatives of ginsenoside on colorectal cancer cells.
    Xia X; Jiang B; Liu W; Wang P; Mou Y; Liu Y; Zhao Y; Bi X
    Steroids; 2014 Feb; 80():24-9. PubMed ID: 24316234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
    Bi X; Xia X; Mou T; Jiang B; Fan D; Wang P; Liu Y; Hou Y; Zhao Y
    Eur J Pharmacol; 2014 Nov; 742():145-52. PubMed ID: 25199964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25-Methoxylprotopanaxadiol derivatives and their anti-proliferative activities.
    Liu YF; Yuan HN; Bi XL; Piao HR; Cao JQ; Li W; Wang P; Zhao YQ
    Steroids; 2013 Dec; 78(14):1305-11. PubMed ID: 24120654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfamic and succinic acid derivatives of 25-OH-PPD and their activities to MCF-7, A-549, HCT-116, and BGC-823 cell lines.
    Zhou WX; Cao JQ; Wang XD; Guo JH; Zhao YQ
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1076-1080. PubMed ID: 28073676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive.
    Wang X; Sun YY; Qu FZ; Su GY; Zhao YQ
    Biomed Pharmacother; 2019 Oct; 118():108589. PubMed ID: 31382131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.
    Wang W; Zhao Y; Rayburn ER; Hill DL; Wang H; Zhang R
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):589-601. PubMed ID: 16924497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol analogs incorporating natural amino acids.
    Wang P; Bi XL; Xu J; Yuan HN; Piao HR; Zhao YQ
    Steroids; 2013 Feb; 78(2):203-9. PubMed ID: 23178255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives.
    Dong H; Bai LP; Wong VK; Zhou H; Wang JR; Liu Y; Jiang ZH; Liu L
    Molecules; 2011 Dec; 16(12):10619-30. PubMed ID: 22183886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial deglycosylation and ketonization of ginsenoside by Cladosporium cladosporioide and their anticancer activity.
    Jin Y; Jung SY; Kim YJ; Lee DY; Aceituno VC; Wang C; Yang DC
    Antonie Van Leeuwenhoek; 2016 Feb; 109(2):179-85. PubMed ID: 26558793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acylation of 25-hydroxyprotopanaxatriol with aromatic acids increases cytotoxicity.
    Lv L; Lu J; Zhang H; Wang X; Su G; Piao H; Zhao Y
    Fitoterapia; 2019 Sep; 137():104279. PubMed ID: 31356850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides.
    Wang W; Rayburn ER; Hao M; Zhao Y; Hill DL; Zhang R; Wang H
    Prostate; 2008 Jun; 68(8):809-19. PubMed ID: 18324646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel 25-hydroxyprotopanaxadiol derivatives by methylation and methoxycarbonylation using dimethyl carbonate as a environment-friendly reagent and their anti-tumor evaluation.
    Guo J; Xu Z; Liu Y; Wang X; Zhao Y
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4763-4768. PubMed ID: 27561718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 25-hydroxyprotopanaxadiol derivatives incorporating chloroacetyl chloride and their anti-tumor evaluation.
    Qu FZ; Liu YF; Cao JQ; Wang XD; Zhang XS; Zhao C; Zhao YQ
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5390-4. PubMed ID: 25453794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esterified Derivatives of Panaxadiol and Their Inhibitory Effect on HL-60, THP-1, and PC-3 Cell Lines.
    Wang Z; Ding M; Lin Z; He C; Zhao Y
    Chem Biodivers; 2019 Aug; 16(8):e1900188. PubMed ID: 31298488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the study of derivatization of ginsenosides and their anti-tumor structure-activity relationship].
    Cao M; Yu HS; Song XB; Ma BP
    Yao Xue Xue Bao; 2012 Jul; 47(7):836-43. PubMed ID: 22993845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol derivatives.
    Wang P; Bi XL; Guo YM; Cao JQ; Zhang SJ; Yuan HN; Piao HR; Zhao YQ
    Eur J Med Chem; 2012 Sep; 55():137-45. PubMed ID: 22840493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.